MedTrace Logo

Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients

NCT03034174 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2023-11-24

No results posted yet for this study

Summary

The objective of this study is to describe the pharmacokinetics of tigecycline in critically ill patients receiving continuous venovenous haemodialysis (CVVHD) and to evaluate the frequency of pharmacokinetic/pharmacodynamic target attainment with high dosing strategy (200 mg loading dose and 100 mg/12h).

Conditions

  • Septic Shock
  • Antibiotic Resistant Infection
  • Critical Illness

Sponsors & Collaborators

  • Medical University of Lublin

    lead OTHER

Principal Investigators

  • Mirosław Czuczwar, M.D. PhD. · Medical University of Lublin

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-15
Primary Completion
2017-12-15
Completion
2018-10-10

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03034174 on ClinicalTrials.gov